Tatva Chintan Pharma Chem Ltd
NSE:TATVA
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
803.8
1 622.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TATVA stock under the Base Case scenario is 922.2 INR. Compared to the current market price of 824.6 INR, Tatva Chintan Pharma Chem Ltd is Undervalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Tatva Chintan Pharma Chem Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for TATVA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Tatva Chintan Pharma Chem Ltd
Balance Sheet Decomposition
Tatva Chintan Pharma Chem Ltd
Current Assets | 3B |
Cash & Short-Term Investments | 490.5m |
Receivables | 722m |
Other Current Assets | 1.8B |
Non-Current Assets | 5.2B |
Long-Term Investments | 42.6m |
PP&E | 5B |
Intangibles | 3.5m |
Other Non-Current Assets | 131.3m |
Current Liabilities | 796.6m |
Accounts Payable | 450.3m |
Other Current Liabilities | 346.3m |
Non-Current Liabilities | 19.7m |
Long-Term Debt | 6.4m |
Other Non-Current Liabilities | 13.3m |
Earnings Waterfall
Tatva Chintan Pharma Chem Ltd
Revenue
|
3.8B
INR
|
Cost of Revenue
|
-1.7B
INR
|
Gross Profit
|
2.1B
INR
|
Operating Expenses
|
-1.8B
INR
|
Operating Income
|
332.1m
INR
|
Other Expenses
|
-71.5m
INR
|
Net Income
|
260.6m
INR
|
Free Cash Flow Analysis
Tatva Chintan Pharma Chem Ltd
INR | |
Free Cash Flow | INR |
TATVA Profitability Score
Profitability Due Diligence
Tatva Chintan Pharma Chem Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Tatva Chintan Pharma Chem Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
TATVA Solvency Score
Solvency Due Diligence
Tatva Chintan Pharma Chem Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Tatva Chintan Pharma Chem Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TATVA Price Targets Summary
Tatva Chintan Pharma Chem Ltd
According to Wall Street analysts, the average 1-year price target for TATVA is 1 091.2 INR with a low forecast of 707 INR and a high forecast of 2 021.25 INR.
Dividends
Current shareholder yield for TATVA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
TATVA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Tatva Chintan Pharma Chem Ltd. is a chemicals manufacturing company. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2021-07-29. The firm is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are quarternary salts, which helps in the formation of channels and pores during the synthesis of zeolites. Its PTCs are used to facilitate the migration of a reactant from one phase into another phase where the reaction occurs in a heterogeneous multi-phase system. The firm operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The firm is focused on serving various customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries.
Contact
IPO
Employees
Officers
The intrinsic value of one TATVA stock under the Base Case scenario is 922.2 INR.
Compared to the current market price of 824.6 INR, Tatva Chintan Pharma Chem Ltd is Undervalued by 11%.